Zobrazeno 1 - 10
of 1 797
pro vyhledávání: ''
Autor:
Assaf, Berger, Kenneth, Bernstein, Juan Diego, Alzate, Reed, Mullen, Joshua S, Silverman, Erik P, Sulman, Bernadine R, Donahue, Anna C, Pavlick, Jason, Gurewitz, Monica, Mureb, Janice, Mehnert, Kathleen, Madden, Amy, Palermo, Jeffrey S, Weber, John G, Golfinos, Douglas, Kondziolka
Publikováno v:
Journal of Neuro-Oncology. 158:471-480
New therapies for melanoma have been associated with increasing survival expectations, as opposed to the dismal outcomes of only a decade ago. Using a prospective registry, we aimed to define current survival goals for melanoma patients with brain me
Autor:
Christelle Nilles, Daniel Delgadillo, Marie Sarazin, Lucia Nichelli, Karima Mokhtari, Bertrand Mathon, Sylvain Choquet, Loïc Feuvret, Agusti Alentorn, Monica Ribeiro, Khê Hoang-Xuan, Caroline Houillier
Publikováno v:
Journal of Neuro-Oncology. 158:99-109
The corpus callosum (CC) is frequently involved in primary central nervous system lymphomas (PCNSLs). In this cohort study, we described the neurocognition of patients with PCNSL-CC and its posttherapeutic evolution.Immunocompetent patients with PCNS
Autor:
Johannes Kerschbaumer, Aleksandrs Krigers, Matthias Demetz, Daniel Pinggera, Julia Klingenschmid, Nadine Pichler, Claudius Thomé, Christian F. Freyschlag
Publikováno v:
Journal of Neuro-Oncology. 158:51-57
Purpose The Clinical Frailty Scale (CFS) evaluates patients’ level of frailty on a scale from 1 to 9 and is commonly used in geriatric medicine, intensive care and orthopedics. The aim of our study was to reveal whether the CFS allows a reliable pr
Autor:
Haley K. Perlow, Alexander Yaney, Michael Yang, Brett Klamer, Jennifer Matsui, Raju R. Raval, Dukagjin M. Blakaj, Andrea Arnett, Sasha Beyer, James B. Elder, Mario Ammirati, Russell Lonser, Douglas Hardesty, Shirley Ong, Pierre Giglio, Clement Pillainayagam, Justin Goranovich, John Grecula, Arnab Chakravarti, Vinai Gondi, Paul D. Brown, Joshua D. Palmer
Publikováno v:
Journal of Neuro-Oncology. 156:399-406
The standard of care for elderly glioblastoma patients is 40 Gy in 15 fraction radiotherapy with temozolomide (TMZ). However, this regimen has a lower biologic equivalent dose (BED) compared to the Stupp regimen of 60 Gy in 30 fractions. We hypothesi
Autor:
Mason Webb, Derek R. Johnson, Anita Mahajan, Paul Brown, Bryan Neth, Sani H. Kizilbash, Ugur Sener
Publikováno v:
Journal of neuro-oncology. 160(2)
Pineal parenchymal tumor of intermediate differentiation (PPTID) is a neoplasm of pinealocyte origin and of intermediate differentiation (WHO grade 2 or 3). Treatment selection and prognostication is challenging for this rare, recently characterized
Autor:
Yasuki Suruga, Kaishi Satomi, Yoshihiro Otani, Kentaro Fujii, Joji Ishida, Atsuhito Uneda, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Naoya Kemmotsu, Ryoji Imoto, Ryo Mizuta, Yusuke Tomita, Takao Yasuhara, Kana Washio, Hiroyuki Yanai, Yuko Matsushita, Yuko Hibiya, Akihiko Yoshida, David Capper, Koichi Ichimura, Isao Date
Publikováno v:
Journal of neuro-oncology. 160(1)
Pilocytic astrocytoma (PA) is a circumscribed low-grade astrocytic glioma, generally considered to be associated with a good prognosis. However, a subset of PA patients shows unfavorable outcomes. In this study, we retrospectively reviewed PA patient
Autor:
Thomas Samoyeau, Corentin Provost, Alexandre Roux, Laurence Legrand, Edouard Dezamis, Geneviève Plu-Bureau, Johan Pallud, Catherine Oppenheim, Joseph Benzakoun
Publikováno v:
Journal of Neuro-Oncology
Journal of Neuro-Oncology, 2022, 160 (1), pp.127-136. ⟨10.1007/s11060-022-04124-2⟩
Journal of Neuro-Oncology, 2022, 160 (1), pp.127-136. ⟨10.1007/s11060-022-04124-2⟩
Purpose: To report the results of systematic meningioma screening program implemented by French authorities in patients exposed to progestin therapies (cyproterone (CPA), nomegestrol (NA), and chlormadinone (CMA) acetate).Methods: We conducted a pros
Changes in survival over time for primary brain and other CNS tumors in the United States, 2004-2017
Autor:
Gino Cioffi, Kristin A. Waite, Jacob L. Edelson, Carol Kruchko, Quinn T. Ostrom, Jill S. Barnholtz-Sloan
Publikováno v:
Journal of neuro-oncology. 160(1)
Purpose Despite advances in cancer diagnosis and clinical care, survival for many primary brain and other central nervous system (CNS) tumors remain poor. This study performs a comprehensive survival analysis on these tumors. Methods Survival differe
Autor:
Minjae Kim, Sooyon Kim, Yae Won Park, Kyunghwa Han, Sung Soo Ahn, Ju Hyung Moon, Eui Hyun Kim, Jinna Kim, Seok-Gu Kang, Jong Hee Chang, Se Hoon Kim, Seung-Koo Lee
Publikováno v:
Journal of neuro-oncology. 159(3)
To investigate whether type-specific sex differences in survival exist independently of clinical and molecular factors in adult-type diffuse gliomas according to the 2021 World Health Organization (WHO) classification.A retrospective chart and imagin
Autor:
Won Kim, Farinaz Ghodrati, Khashayar Mozaffari, H. Milan Samarage, Ashley B. Zhang, Anjali Pradhan, Jivianne T. Lee, Robert A. Goldberg, Isaac Yang
Publikováno v:
Journal of neuro-oncology, vol 160, iss 3
Purpose Spheno-orbital meningiomas are rare tumors, accounting for up to 9% of all intracranial meningiomas. Patients commonly present with proptosis, and visual deficits. These slow growing tumors are hard to resect due to extension into several ana